Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968–1997
Corresponding Author
Lars Klaeboe
Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, Norway
Fax: +47-2245-1370
Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, N-0310, NorwaySearch for more papers by this authorStefan Lonn
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorDavid Scheie
Department of Pathology, Rikshospitalet University Hospital, Oslo, Norway
Search for more papers by this authorAnssi Auvinen
Finnish Cancer Registry, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorHelle C. Christensen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorMaria Feychting
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorChristoffer Johansen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorTiina Salminen
Tampere School of Public Health, University of Tampere, Tampere, Finland
STUK—Radiation and Nuclear Safety, Helsinki, Finland
Search for more papers by this authorTore Tynes
Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, Norway
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorCorresponding Author
Lars Klaeboe
Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, Norway
Fax: +47-2245-1370
Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, N-0310, NorwaySearch for more papers by this authorStefan Lonn
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorDavid Scheie
Department of Pathology, Rikshospitalet University Hospital, Oslo, Norway
Search for more papers by this authorAnssi Auvinen
Finnish Cancer Registry, Helsinki, Finland
Tampere School of Public Health, University of Tampere, Tampere, Finland
Search for more papers by this authorHelle C. Christensen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorMaria Feychting
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Search for more papers by this authorChristoffer Johansen
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark
Search for more papers by this authorTiina Salminen
Tampere School of Public Health, University of Tampere, Tampere, Finland
STUK—Radiation and Nuclear Safety, Helsinki, Finland
Search for more papers by this authorTore Tynes
Institute of Population-Based Cancer Research, Cancer Registry of Norway, Oslo, Norway
Norwegian Radiation Protection Authority, Østerås, Norway
Search for more papers by this authorAbstract
It has been reported that the incidence of meningioma increased in several industrialized countries in the late 1970s and early 1980s. The aim of this study was to evaluate the time trends in incidence of meningiomas in Denmark, Finland, Norway and Sweden, with emphasis on the age distribution and sex ratio. Information about cases of meningiomas in people aged 15–84 years was obtained from the cancer registries of these Nordic countries for the years 1968–1997, and estimates of person-years at risk were calculated from information provided by the national population registries. Age-specific incidence rates per 100,000 and incidence rate ratios were calculated for 3-year periods. The female:male ratios were also evaluated. The combined incidence among men increased from 1.4 to 1.9 per 100,000 during the follow-up period, the corresponding rates for women were 2.6 and 4.5. The female:male ratio increased over time for several age groups and was as high as 3.5:1 in the group aged 40–44 years in the latest follow-up period (1993–1997). In summary, our results provide some support for the idea that the introduction of computed tomography in the late 1970s has had an impact on the detection of cases in people aged 60 and over. The decrease in the rate or detection postmortem has affected the incidence time trend, but it also coincides with widespread use of new imaging technologies. The increasing trend shown for the female:male ratio in the group aged 35–59 years is consistent with the possibility that increasing use of hormones may affect the incidence of meningiomas in women. © 2005 Wiley-Liss, Inc.
References
- 1 P Kleihues, WK Cavenee, eds. WHO classification of tumours: pathology and genetics of tumours of the nervous system. Lyon: IARC Press, 2000.
- 2 Andersen C. Intracranial meningioma: new knowledge. Ugeskr Laeger 2001; 163: 2618–22.
- 3 Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neuro-oncol 1996; 29: 197–205.
- 4 Helseth A. Incidence and survival of intracranial meningioma patients in Norway 1963–1992. Neuroepidemiology 1997; 16: 53–9.
- 5 Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 2002; 97: 1078–82.
- 6 Rachlin JR, Rosenblum ML. Etiology and biology of meningiomas. In: O Al-Mefty, ed. Meningiomas. New York: Raven, 1991. 27–35.
- 7 Ron E, Modan B, Boice JDJr, Alfandary E, Stovall M, Chetrit A, Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988; 319: 1033–9.
- 8 Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumors and menopausal status. J Natl Cancer Inst 1992; 84: 1346–9.
- 9 Al-Mefty O. Meningiomas. New York: Raven Press, 1991.
- 10 Phillips LE, Koepsell TD, van Belle G, Kukull WA, Gehrels JA, Longstreth WTJr. History of head trauma and risk of intracranial meningioma: population-based case-control study. Neurology 2002; 58: 1849–52.
- 11 Preston-Martin S, Pogoda JM, Schlehofer B, Blettner M, Howe GR, Ryan P, Menegoz F, Giles GG, Rodvall Y, Choi NW, Little J, Arslan A. An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol 1998; 27: 579–86.
- 12 Ahlbom IC, Cardis E, Green A, Linet M, Savitz D, Swerdlow A, ICNIRP (International Commission for Non-Ionizing Radiation Protection) Standing Committee on Epidemiology. Review of the epidemiologic literature on EMF and health. Environ Health Perspect 2001; 109( Suppl 6): 911–33.
- 13 Ahlbom A, Green A, Kheifets L, Savitz D, Swerdlow A, ICNIRP (International Commission for Non-Ionizing Radiation Protection) Standing Committee on Epidemiology. Epidemiology of health effects of radiofrequency exposure. Environ Health Perspect 2004; 112: 1741–54.
- 14 Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG. Trends in incidence of primary brain tumors in the United States,1985–1994. Neuro-oncology 2001; 3: 141–51.
- 15 American Cancer Society. Manual of tumour nomenclature and coding. Washington, DC: American Cancer Society, 1968.
- 16 Svendsen E, Hill RB. Autopsy legislation and practice in various countries. Arch Pathol Lab Med 1987; 111: 846–50.
- 17 O'Conor GT. Contribution of post-mortem examination to cancer registries. In: E Riboli, M Delendi, eds. Autopsy in epidemiology and medical research. Lyon: IARC, 1991. 197–206.
- 18 Doll R, Payne P, Waterhouse JAH. Cancer incidence in five continents. vol. 1. Berlin: Springer, 1966.
- 19 Kleihues P, Burger PC, Scheithauer BW, World Health Organization. International histological classification of tumours. Berlin: New York: Springer, 1993.
- 20 Helseth A. The incidence of primary central nervous system neoplasms before and after computerized tomography availability. J Neurosurg 1995; 83: 999–1003.
- 21 Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, Linet MS. Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst 1999; 91: 1382–90.
- 22 Modan B, Wagener DK, Feldman JJ, Rosenberg HM, Feinleib M. Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol 1992; 135: 1349–57.
- 23 Boyle P, Maisonneuve P, Saracci R, Muir CS. Is the increased incidence of primary malignant brain tumors in the elderly real? J Natl Cancer Inst 1990; 82: 1594–6.
- 24 Gurney JG, Kadan-Lottick N. Brain and other central nervous system tumors: rates, trends, and epidemiology. Curr Opin Oncol 2001; 13: 160–6.
- 25 Christensen HC, Kosteljanetz M, Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 2003; 52: 1327–33.
- 26 United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation: UNSCEAR 2000 report. vol. 1. New York: United Nations Scientific Committee on the Effects of Atomic Radiation, 2000.
- 27 Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS 1995; 103( suppl 49): 1–161.
- 28 Jensen OM, Storm HH, Jensen HS. Cancer registration in Denmark and the study of multiple primary cancers,1943–80. Natl Cancer Inst Monogr 1985; 68: 245–51.
- 29 Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry: experience in Finland. Acta Oncol 1994; 33: 365–9.
- 30 Lund E. Pilot study for the evaluation of completeness of reporting to the cancer registry: incidence of cancer in Norway 1978. Oslo: Cancer Registry of Norway, 1981. 11–4.
- 31 Mattsson B, Wallgren A. Completeness of the Swedish cancer register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305–13.
- 32 Codd MB, Kurland LT. Descriptive epidemiology of primary intracranial neoplasms. Prog Exp Tumor Res 1985; 29: 1–11.
- 33 Sternby NH. The role of autopsy in cancer registration in Sweden, with particular reference to findings in Malmö. In: E Riboli, M Delendi, eds. Autopsy in epidemiology and medical research. Lyon: IARC, 1991. 217–22.
- 34 Helseth A, Mork SJ, Johansen A, Tretli S. Neoplasms of the central nervous system in Norway: IV, a population-based epidemiological study of meningiomas. APMIS 1989; 97: 646–54.
- 35 NOMESCO. Health statistics in the Nordic countries 2001. Copenhagen: Nordic Medico-Statistical Committee, 2003. 174.
- 36 NOMESCO. Health statistics in the Nordic countries 1993. Copenhagen: Nordic Medico-Statistical Committee, 1995. 62.
- 37 Topo P, Koster A, Holte A, Collins A, Landgren BM, Hemminki E, Uutela A. Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas 1995; 22: 89–95.
- 38 Carroll RS, Glowacka D, Dashner K, Black PM. Progesterone receptor expression in meningiomas. Cancer Res 1993; 53: 1312–6.
- 39 Inoue T, Akahira J, Suzuki T, Darnel AD, Kaneko C, Takahashi K, Hatori M, Shirane R, Kumabe T, Kurokawa Y, Satomi S, Sasano H. Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab 2002; 87: 5325–31.
- 40 Lonn S, Ahlbom A, Hall P, Feychting M. Swedish Interphone Study Group. Long-term mobile phone use and brain tumor risk. Am J Epidemiol 2005; 161: 526–35.
- 41 Christensen HC, Schütz J, Kosteljanetz M, Poulsen HS, Boice JD Jr, McLaughlin JK, Johansen C. Cellular telephones and risk for brain tumors: A population-based,incident case-control study. Neurology 2005; 64: 1189–95.